Actively Recruiting
Post-Market Evaluation of the Z1 Femoral Hip System in Hip Replacement Surgery
Led by Zimmer Biomet · Updated on 2026-10-16
300
Participants Needed
5
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, performance, and clinical benefits of the Z1 Femoral Hip System in patients undergoing hemi-hip or primary total hip arthroplasty. This study includes two patient groups Cohort 0 focuses on implant survival and safety over 2 years, while Cohort 1 primarily assesses patient-reported clinical outcomes after 2 years. Secondary and exploratory outcomes include hip function scores, patient satisfaction, and radiographic results. The Z1 Femoral Hip System consists of a femoral stem, femoral head, and acetabular components made from durable, biocompatible materials like titanium alloys and ceramics. The system is designed for implantation in the proximal femur during hip replacement surgery and includes various stem sizes and neck lengths to fit different anatomies. The device is used with compatible Zimmer Biomet components and implanted during standard surgical procedures. Participants will be monitored through scheduled evaluations including assessments of implant survival, adverse events, and hip function scores such as the Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement HOOS JR. Patient satisfaction and quality of life measures EQ-5D will also be collected. The study follows participants for up to 2 years post-surgery to evaluate the devices safety and effectiveness in routine clinical use.
CONDITIONS
Brief Title
Z1 Hip System: Post-Market Clinical Follow Up Study
Research Team
T
Taylor Rowe
L
Lynsey Boyle
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here